Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Horne

Showing results (71-80 of 170) with videos related to

Pageof 17
Sort By:
European Journal of Medical Research|December 19, 2024
Unmasking culprits: novel analysis identifies complement factors as potential therapeutic targets to mitigate inflammation during children's heart surgeryJoel Bierer, Roger Stanzel, Mark Henderson, et al.
The Canadian Journal of Cardiology|January 22, 2013
Adult presentation with a bilobed membranous ventricular septal aneurysmDavid Horne, Christopher W White, G Scott Mackenzie, et al.
Cancer Letters|May 11, 2020
Therapeutic targeting of miRNA-216b in cancerSamir Jana, Madhu Krishna, Jyotsana Singhal, et al.
Biochemical Pharmacology|March 6, 2025
Strategic advancements in targeting the PI3K/AKT/mTOR pathway for Breast cancer therapyPankaj Garg, Sravani Ramisetty, Meera Nair, et al.
Perfusion|October 9, 2024
Sanguineous cardiopulmonary bypass prime accelerates the inflammatory response during pediatric cardiac surgeryJoel Bierer, Roger Stanzel, Mark Henderson, et al.
Journal of Clinical Medicine|July 27, 2024
Advances in Non-Small Cell Lung Cancer: Current Insights and Future DirectionsPankaj Garg, Sulabh Singhal, Prakash Kulkarni, et al.
Angewandte Chemie (International Ed. in English)|November 11, 2014
Enantioselective synthesis of α-secondary and α-tertiary piperazin-2-ones and piperazines by catalytic asymmetric allylic alkylationKaterina M Korch, Christian Eidamshaus, Douglas C Behenna, et al.
Pharmaceutical Research|April 8, 2017
RLIP76 Inhibition: A Promising Developmental Therapy for NeuroblastomaSharad S Singhal, Lokesh Nagaprashantha, Preeti Singhal, et al.
Oncogene|March 30, 2004
The cell cycle checkpoint kinase Chk2 is a negative regulator of mitotic catastropheMaria Castedo, Jean-Luc Perfettini, Thomas Roumier, et al.
Journal of Molecular Graphics & Modelling|September 29, 2009
Molecular dynamics simulations of the conformational changes in signal transducers and activators of transcription, Stat1 and Stat3Jianping Lin, Ralf Buettner, Yate-Ching Yuan, et al.
Pageof 17

Showing results (71-80 of 170) with videos related to

Sort By:
Pageof 17
European Journal of Medical Research|December 19, 2024
Unmasking culprits: novel analysis identifies complement factors as potential therapeutic targets to mitigate inflammation during children's heart surgeryJoel Bierer, Roger Stanzel, Mark Henderson, et al.
The Canadian Journal of Cardiology|January 22, 2013
Adult presentation with a bilobed membranous ventricular septal aneurysmDavid Horne, Christopher W White, G Scott Mackenzie, et al.
Cancer Letters|May 11, 2020
Therapeutic targeting of miRNA-216b in cancerSamir Jana, Madhu Krishna, Jyotsana Singhal, et al.
Biochemical Pharmacology|March 6, 2025
Strategic advancements in targeting the PI3K/AKT/mTOR pathway for Breast cancer therapyPankaj Garg, Sravani Ramisetty, Meera Nair, et al.
Perfusion|October 9, 2024
Sanguineous cardiopulmonary bypass prime accelerates the inflammatory response during pediatric cardiac surgeryJoel Bierer, Roger Stanzel, Mark Henderson, et al.
Journal of Clinical Medicine|July 27, 2024
Advances in Non-Small Cell Lung Cancer: Current Insights and Future DirectionsPankaj Garg, Sulabh Singhal, Prakash Kulkarni, et al.
Angewandte Chemie (International Ed. in English)|November 11, 2014
Enantioselective synthesis of α-secondary and α-tertiary piperazin-2-ones and piperazines by catalytic asymmetric allylic alkylationKaterina M Korch, Christian Eidamshaus, Douglas C Behenna, et al.
Pharmaceutical Research|April 8, 2017
RLIP76 Inhibition: A Promising Developmental Therapy for NeuroblastomaSharad S Singhal, Lokesh Nagaprashantha, Preeti Singhal, et al.
Oncogene|March 30, 2004
The cell cycle checkpoint kinase Chk2 is a negative regulator of mitotic catastropheMaria Castedo, Jean-Luc Perfettini, Thomas Roumier, et al.
Journal of Molecular Graphics & Modelling|September 29, 2009
Molecular dynamics simulations of the conformational changes in signal transducers and activators of transcription, Stat1 and Stat3Jianping Lin, Ralf Buettner, Yate-Ching Yuan, et al.
Pageof 17